Search Results - "Dueland, Svein"

Refine Results
  1. 1

    Patterns of Recurrence After Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer by Hagness, Morten, Foss, Aksel, Egge, Tor Skatvedt, Dueland, Svein

    Published in Annals of surgical oncology (01-04-2014)
    “…Background Surgical resection is the only curative modality for colorectal liver metastases (CLM), and the pattern of recurrences after resection affects…”
    Get full text
    Journal Article
  2. 2

    Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study by Grut, Harald, Line, Pål-Dag, Syversveen, Trygve, Dueland, Svein

    Published in Annals of nuclear medicine (01-12-2022)
    “…Objective To report 15 years of experience with metabolic tumor volume (MTV) of liver metastases from the preoperative 18 F-FDG PET/CT to predict long-term…”
    Get full text
    Journal Article
  3. 3

    Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer? by Dueland, Svein, Guren, Tormod K, Hagness, Morten, Glimelius, Bengt, Line, Pål-Dag, Pfeiffer, Per, Foss, Aksel, Tveit, Kjell M

    Published in Annals of surgery (01-05-2015)
    “…OBJECTIVE:The primary objective was to compare overall survival (OS) in patients with colorectal cancer (CRC) with nonresectable liver-only metastases treated…”
    Get full text
    Journal Article
  4. 4

    Liver transplantation for nonresectable liver metastases from colorectal cancer by Hagness, Morten, Foss, Aksel, Line, Pål-Dag, Scholz, Tim, Jørgensen, Pål Foyn, Fosby, Bjarte, Boberg, Kirsten Muri, Mathisen, Oystein, Gladhaug, Ivar P, Egge, Tor Skatvedt, Solberg, Steinar, Hausken, John, Dueland, Svein

    Published in Annals of surgery (01-05-2013)
    “…The objective of this pilot study was to investigate the potential for long-term overall survival (OS) after liver transplantation for colorectal liver…”
    Get full text
    Journal Article
  5. 5

    Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer by Bains, Simer J., Abrahamsson, Hanna, Flatmark, Kjersti, Dueland, Svein, Hole, Knut H., Seierstad, Therese, Redalen, Kathrine Røe, Meltzer, Sebastian, Ree, Anne Hansen

    Published in Cancer Immunology, Immunotherapy (01-03-2020)
    “…Objective High rates of systemic failure in locally advanced rectal cancer call for a rational use of conventional therapies to foster tumor-defeating…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases by Line, Pål-Dag, Dueland, Svein, Hagness, Morten

    “…Liver resection is the only potentially curative treatment option in patients with liver metastases from colorectal cancer, but only about 20% of the patients…”
    Get full text
    Journal Article
  11. 11
  12. 12

    IL-7 is expressed and secreted by human skeletal muscle cells by Haugen, Fred, Norheim, Frode, Lian, Henrik, Wensaas, Andreas J, Dueland, Svein, Berg, Ole, Funderud, Ane, Skålhegg, Bjørn S, Raastad, Truls, Drevon, Christian A

    “…In addition to generating movement, skeletal muscle may have a function as a secretory organ. The aim of the present study was to identify novel proteins with…”
    Get more information
    Journal Article
  13. 13

    Liver transplantation for colorectal liver metastases: revisiting the concept by Foss, Aksel, Adam, Rene, Dueland, Svein

    Published in Transplant international (01-07-2010)
    “…Liver transplantation (Lt) for colorectal cancer (CRC) liver metastases is no more considered due to the poor outcome observed up to the 1990s. According to…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer by Meltzer, Sebastian, Bjørnetrø, Tonje, Lyckander, Lars Gustav, Flatmark, Kjersti, Dueland, Svein, Samiappan, Rampradeep, Johansen, Christin, Kalanxhi, Erta, Ree, Anne Hansen, Redalen, Kathrine Røe

    Published in Translational oncology (01-08-2019)
    “…As many as 30% to 40% of locally advanced rectal cancer (LARC) patients experience metastatic progression of the disease. Recognizing the potential of the…”
    Get full text
    Journal Article
  16. 16

    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer by Abrahamsson, Hanna, Porojnicu, Alina C, Lindstrøm, Jonas C, Dueland, Svein, Flatmark, Kjersti, Hole, Knut H, Seierstad, Therese, Moan, Johan, Redalen, Kathrine Røe, Meltzer, Sebastian, Ree, Anne Hansen

    Published in BMC cancer (23-05-2019)
    “…Following curative-intent neoadjuvant therapy in locally advanced rectal cancer, metastatic progression is still dominant. We investigated if patients'…”
    Get full text
    Journal Article
  17. 17
  18. 18

    High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer by Redalen, Kathrine Røe, Sitter, Beathe, Bathen, Tone Frost, Grøholt, Krystyna K, Hole, Knut Håkon, Dueland, Svein, Flatmark, Kjersti, Ree, Anne Hansen, Seierstad, Therese

    Published in Radiotherapy and oncology (01-02-2016)
    “…Abstract Background and purpose Recognizing the link between altered tumor metabolism and disease aggressiveness, this study aimed to identify associations…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer by Bousquet, Paula A., Meltzer, Sebastian, Sønstevold, Linda, Esbensen, Ying, Dueland, Svein, Flatmark, Kjersti, Sitter, Beathe, Bathen, Tone Frost, Seierstad, Therese, Redalen, Kathrine Røe, Eide, Lars, Ree, Anne Hansen

    Published in Translational oncology (01-01-2019)
    “…Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial…”
    Get full text
    Journal Article